MISSISSAUGA, ON, July 24, 2015 /CNW/ - Mr.
Jakob Riis, Executive Vice
President, China, Pacific &
Marketing, Novo Nordisk A/S, is pleased to announce the appointment
of Mr. Brian Hilberdink to the role
of President, Novo Nordisk Canada Inc.
Mr. Hilberdink is an accomplished executive with 20 years of
global and domestic experience developing and executing Novo
Nordisk's commercial strategy. He previously held the position of
Vice President, Diabetes Marketing and Market Access, Novo Nordisk
Canada. Prior to this role, Brian was Corporate Vice President,
Global Marketing, Novo Nordisk A/S, and led the commercialization
of the company's future insulin portfolio, from phase 2 clinical
development until the first launches in Europe and Japan. He also has experience working in the
U.S. where, as Director, Brand
Management, he led multiple brand teams during a period of
significant growth for Novo Nordisk U.S.
"I'm truly honoured to be part of an organization that has
played a central role in helping to defeat diabetes and other
serious chronic conditions, such as hemophilia, growth disorders
and obesity," said Brian Hilberdink,
President, Novo Nordisk Canada. "Moving forward, I am excited about
the opportunity to have an even greater impact in Canada through the development of strong
partnerships and the offering of new products and services to best
support patients, their families and healthcare professionals."
About Novo Nordisk
Novo Nordisk is a global healthcare
company with more than 90 years of innovation and leadership in
diabetes care. This heritage has given us experience and
capabilities that also enable us to help people defeat other
serious chronic conditions: hemophilia, growth disorders and
obesity. Headquartered in Denmark,
Novo Nordisk employs approximately 39,000 people in 75 countries
and markets its products in more than 180 countries. For more
information, visit novonordisk.com, Facebook, Twitter, LinkedIn,
YouTube
SOURCE Novo Nordisk Canada Inc.